Dose Escalation Study of Kylo-0603 in Healthy Subjects

Clinical trial NCT06365580 · COMPLETED

Trial details

NCT number: NCT06365580
Sponsor: Kylonova (Xiamen) Biopharma co., LTD.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Nonalcoholic Steatohepatitis

Start date: 2023-05-23
Primary completion: 2024-08-16
Enrollment: 132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.